Spina bifida (SB) refers to a wide range of neural tube defects, a neuro-urological disease affecting the spine and spinal cord. With a marked geographic and ethnic variation, SB has an incidence of 1-5 cases per 1000 live births. In Turkey, the incidence is 3 per 1000 live births (1), and in the eastern region of Turkey, it is 2.2 per 1000 live births (2). The basic urological problem in SB is neurogenic bladder dysfunction, resulting in urinary tract infections (UTI), incontinence, vesicoureteral reflux (VUR), hydronephrosis, chronic kidney disease (CKD), hypertension, and end-stage renal failure (3). The goal of treatment is to reduce bladder pressure and minimize urine stasis, thus preventing recurrent febrile UTI and consequent function loss. Patients should be followed up regularly against late referral because SB management is a dynamic and long-lasting process for a life time, and patient selection for aggressive treatment may prevent renal parenchymal deterioration (4).Although renal ultrasonography (US) is used to demonstrate renal anomalies, urinary tract dilatation, signs of neurogenic bladder, renal scarring, and presumed function of the kidney, Tc99m DMSA scintigraphy is the best for detecting renal parenchymal defects and demonstrating renal function loss with decreased differential function of the kidney. Single defects resulting in a localized deformity of renal outlines are the result of scarring and show no improvement on subsequent studies. The total renal Dimercaptosuccinic acid (DMSA) uptake is a measure of individual renal function (5). Follow-up studies with scintigraphy and US are conducted to confirm the resolution of pyelonephritic defect(s), evaluation of cortical scarring, and function loss. Patients with scarring are periodically followed up for assessment of progressive renal insufficiency. Tc-99m DMSA scintigraphy demonstrates approximately twice as many defects as renal US in the normal population (6). We hypothesized that this proportion may increase in SB patients because SB patients usually have rotoscoliosis, obesity, renal position anomalies, and intestinal gas distention that may corrupt the imaging quality of US, whereas these imaging difficulties do not affect the imaging quality of Tc-99m DMSA scintigraphy. We studied the efficiency of Tc-99m DMSA scintigraphy and renal US in the detection of renal scarring and function loss in children with SB.
Comparison between Tc-99m DMSA and Renal Ultrasonography for the Evaluation of Renal Scarring and Function Loss in Children with Spina BifidaObjective: We aimed to compare the sensitivity of ultrasonography (US) and Dimercaptosuccinic acid (DMSA) scintigraphy in evaluating renal scarring and kidney function in children with spina bifida (SB).
Methods:The study group comprised 100 patients (51 boys and 49 girls) with SB who underwent renal US and DMSA scintigraphy. The median age was 2 years (range: 6 months -23 years). Renal US scans were performed by applying standard protocols. Subsequently, DMSA scintigraphy was performed to e...